Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Risk factors for peptic ulcer bleeding one year after the initial episode

Authors: Yu-Xuan Peng, Wen-Pei Chang

Published in: Gut Pathogens | Issue 1/2024

Login to get access

Abstract

Background

Peptic ulcers are a common gastrointestinal disease that could cause death when combined with bleeding. The aim of this study was to identify risk factors for peptic ulcer bleeding (PUB) recurrence after the initial episode.

Methods

This retrospective study analyzed medical records of PUB patients who were admitted through the emergency department between January 1, 2020, and December 31, 2022. A multivariate logistic regression model was used to identify independent risk factors predicting readmission due to recurrent PUB within one year.

Results

A total of 775 PUB inpatient samples were collected, among which 172 and 603 were placed respectively in the readmission group and non-readmission group. Multivariate analysis indicated that PUB inpatients who were aged 70 or above (OR = 1.62, 95% CI: 1.06–2.47), had more severe ulcers (Forrest 1a, 1b, 2a, or 2b) (OR = 2.41, 95% CI:1.57–3.71), had a CCI score of 3 or higher (OR = 2.25, 95% CI:1.45–3.50), had a medical history of peptic ulcers (OR = 3.87, 95% CI:2.56–5.85), had a medical history of cardiovascular disease (CVD) (OR = 2.31, 95% CI:1.53–3.50), or had an international normalized ratio (INR) > 1.2 on admission (OR = 2.14, 95% CI:1.28–3.57) were respectively more likely to be readmitted within a year due to PUB than those who were under the age of 70, had less severe ulcers (Forrest 2c or 3), had a CCI score of less than 3, had no medical history of peptic ulcers, had no medical history of CVD, or had admission INR ≤ 1.2.

Conclusion

This study confirmed that age (≥70 years), Forest classification (Forrest 1a, 1b, 2a, or 2b), multiple comorbidities, a medical history of peptic ulcers, a medical history of CVD, and admission INR > 1.2 were independent risk factors for patient readmission within a year due to recurrent PUB.
Literature
2.
go back to reference Petrik P, Brašiškienė S, Petrik E. Characteristics and outcomes of gastroduodenal ulcer bleeding: a single-centre experience in Lithuania. Prz Gastroenterol. 2017;12(4):277–85.PubMedPubMedCentral Petrik P, Brašiškienė S, Petrik E. Characteristics and outcomes of gastroduodenal ulcer bleeding: a single-centre experience in Lithuania. Prz Gastroenterol. 2017;12(4):277–85.PubMedPubMedCentral
3.
go back to reference Bitar SM, Moussa M. The risk factors for the recurrent upper gastrointestinal hemorrhage among acute peptic ulcer disease patients in Syria: a prospective cohort study. Ann Med Surg (Lond). 2022;74:103252.PubMed Bitar SM, Moussa M. The risk factors for the recurrent upper gastrointestinal hemorrhage among acute peptic ulcer disease patients in Syria: a prospective cohort study. Ann Med Surg (Lond). 2022;74:103252.PubMed
5.
go back to reference Negash S, Jembere T, Abera G, Kedir E, Eshetu B. Gastric outlet obstruction due to peptic ulcer disease in a 5 years-old female child. Case report. June 23, 2022. Int J Surg Case Rep. 2023;105:108086.PubMedPubMedCentralCrossRef Negash S, Jembere T, Abera G, Kedir E, Eshetu B. Gastric outlet obstruction due to peptic ulcer disease in a 5 years-old female child. Case report. June 23, 2022. Int J Surg Case Rep. 2023;105:108086.PubMedPubMedCentralCrossRef
6.
go back to reference Paragomi P, Dabo B, Pelucchi C, et al. The association between peptic ulcer disease and gastric cancer: results from the stomach Cancer Pooling (StoP) Project Consortium. Cancers (Basel). 2022;14(19):4905.PubMedCrossRef Paragomi P, Dabo B, Pelucchi C, et al. The association between peptic ulcer disease and gastric cancer: results from the stomach Cancer Pooling (StoP) Project Consortium. Cancers (Basel). 2022;14(19):4905.PubMedCrossRef
7.
go back to reference Al Mutawa OA, Izhari MA, Alharbi RA, et al. Helicobacter pylori (H. Pylori) infection-associated anemia in the Asir Region, Saudi Arabia. Diagnostics (Basel). 2023;13(14):2404.PubMedCrossRef Al Mutawa OA, Izhari MA, Alharbi RA, et al. Helicobacter pylori (H. Pylori) infection-associated anemia in the Asir Region, Saudi Arabia. Diagnostics (Basel). 2023;13(14):2404.PubMedCrossRef
8.
go back to reference Lanas A, Dumonceau JM, Hunt RH, et al. Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Primers. 2018;4:18020.PubMedCrossRef Lanas A, Dumonceau JM, Hunt RH, et al. Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Primers. 2018;4:18020.PubMedCrossRef
10.
go back to reference Deng Z, Zhu J, Ma Z, Yi Z, Tuo B, Li T, Liu X. The mechanisms of gastric mucosal injury: focus on initial chief cell loss as a key target. Cell Death Discov. 202;9(1):29. Deng Z, Zhu J, Ma Z, Yi Z, Tuo B, Li T, Liu X. The mechanisms of gastric mucosal injury: focus on initial chief cell loss as a key target. Cell Death Discov. 202;9(1):29.
11.
go back to reference Nazarian S, Lo FPW, Qiu J, Patel N, Lo B, Ayaru L. Development and validation of machine learning models to predict the need for haemostatic therapy in acute upper gastrointestinal bleeding. Ther Adv Gastrointest Endosc. 2024;17:26317745241246899.PubMedPubMedCentralCrossRef Nazarian S, Lo FPW, Qiu J, Patel N, Lo B, Ayaru L. Development and validation of machine learning models to predict the need for haemostatic therapy in acute upper gastrointestinal bleeding. Ther Adv Gastrointest Endosc. 2024;17:26317745241246899.PubMedPubMedCentralCrossRef
12.
go back to reference Lai Y, Xu Y, Zhu Z, et al. Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding. BMC Gastroenterol. 2022;22(1):64.PubMedPubMedCentralCrossRef Lai Y, Xu Y, Zhu Z, et al. Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding. BMC Gastroenterol. 2022;22(1):64.PubMedPubMedCentralCrossRef
13.
go back to reference Bitar SM, Moussa M. The risk factors for the recurrent upper gastrointestinal hemorrhage among acute peptic ulcer disease patients in Syria: a prospective cohort study. Ann Med Surg. 2022;74:103252.CrossRef Bitar SM, Moussa M. The risk factors for the recurrent upper gastrointestinal hemorrhage among acute peptic ulcer disease patients in Syria: a prospective cohort study. Ann Med Surg. 2022;74:103252.CrossRef
14.
go back to reference Camus M, Jensen DM, Kovacs TO, Jensen ME, Markovic D, Gornbein J. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse. Aliment Pharmacol Ther. 2016;43(10):1080–9.PubMedPubMedCentralCrossRef Camus M, Jensen DM, Kovacs TO, Jensen ME, Markovic D, Gornbein J. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse. Aliment Pharmacol Ther. 2016;43(10):1080–9.PubMedPubMedCentralCrossRef
15.
go back to reference El Ouali S, Barkun A, Martel M, Maggio D. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review. Can J Gastroenterol Hepatol. 2014;28(10):543–8.PubMedPubMedCentralCrossRef El Ouali S, Barkun A, Martel M, Maggio D. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review. Can J Gastroenterol Hepatol. 2014;28(10):543–8.PubMedPubMedCentralCrossRef
16.
go back to reference Ogiyama H, Tsutsui S, Murayama Y, et al. Renal dysfunction is an independent risk factor for rebleeding after endoscopic hemostasis in patients with peptic ulcer bleeding. Turk J Gastroenterol. 2021;32(8):622–30.PubMedPubMedCentralCrossRef Ogiyama H, Tsutsui S, Murayama Y, et al. Renal dysfunction is an independent risk factor for rebleeding after endoscopic hemostasis in patients with peptic ulcer bleeding. Turk J Gastroenterol. 2021;32(8):622–30.PubMedPubMedCentralCrossRef
17.
go back to reference Eisner F, Hermann D, Bajaeifer K, Glatzle J, Königsrainer A, Küper MA. Gastric ulcer complications after the introduction of proton pump inhibitors into clinical routine: 20-year experience. Visc Med. 2017;33(3):221–6.PubMedPubMedCentralCrossRef Eisner F, Hermann D, Bajaeifer K, Glatzle J, Königsrainer A, Küper MA. Gastric ulcer complications after the introduction of proton pump inhibitors into clinical routine: 20-year experience. Visc Med. 2017;33(3):221–6.PubMedPubMedCentralCrossRef
18.
go back to reference Bini EJ, Cohen J. Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc. 2003;58(5):707–14.PubMedCrossRef Bini EJ, Cohen J. Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc. 2003;58(5):707–14.PubMedCrossRef
19.
go back to reference Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995;41:5–7.PubMedCrossRef Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995;41:5–7.PubMedCrossRef
20.
go back to reference Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995;41(1):1–4.PubMedCrossRef Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995;41(1):1–4.PubMedCrossRef
21.
go back to reference Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489. Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489.
22.
go back to reference Lee SB, Oh JH, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clin Exp Emerg Med. 2018;5(4):249–55.PubMedPubMedCentralCrossRef Lee SB, Oh JH, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clin Exp Emerg Med. 2018;5(4):249–55.PubMedPubMedCentralCrossRef
23.
go back to reference Fryar CD, Kruszon-Moran D, Gu Q, Ogden CL. Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999–2000 through 2015–2016. Natl Health Stat Rep. 2018;(122):1–16. Fryar CD, Kruszon-Moran D, Gu Q, Ogden CL. Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999–2000 through 2015–2016. Natl Health Stat Rep. 2018;(122):1–16.
24.
go back to reference Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res. 2018;11:851–6.PubMedPubMedCentralCrossRef Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res. 2018;11:851–6.PubMedPubMedCentralCrossRef
25.
go back to reference Yen HH, Wu PY, Wu TL, et al. Forrest classification for bleeding peptic ulcer: a new look at the old endoscopic classification. Diagnostics. 2022;12(5):1066.PubMedPubMedCentralCrossRef Yen HH, Wu PY, Wu TL, et al. Forrest classification for bleeding peptic ulcer: a new look at the old endoscopic classification. Diagnostics. 2022;12(5):1066.PubMedPubMedCentralCrossRef
26.
go back to reference Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171(11):805–22.PubMedPubMedCentralCrossRef Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171(11):805–22.PubMedPubMedCentralCrossRef
27.
go back to reference ASGE technology committee, Parsi MA, Schulman AR, et al. Devices for endoscopic hemostasis of nonvariceal GI bleeding (with videos). VideoGIE. 2019;4(7):285–99.PubMedCentralCrossRef ASGE technology committee, Parsi MA, Schulman AR, et al. Devices for endoscopic hemostasis of nonvariceal GI bleeding (with videos). VideoGIE. 2019;4(7):285–99.PubMedCentralCrossRef
28.
go back to reference Yang EH, Wu CT, Kuo HY, Chen WY, Sheu BS, Cheng HC. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6. Surg Endosc. 2020;34(4):1592–601.PubMedCrossRef Yang EH, Wu CT, Kuo HY, Chen WY, Sheu BS, Cheng HC. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6. Surg Endosc. 2020;34(4):1592–601.PubMedCrossRef
29.
go back to reference Wu CY, Wu CH, Wu MS, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7(4):427–31.PubMedCrossRef Wu CY, Wu CH, Wu MS, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7(4):427–31.PubMedCrossRef
30.
go back to reference Chang SS, Hu HY. Helicobacter pylori eradication within 120 days is associated with decreased complicated recurrent peptic ulcers in peptic ulcer bleeding patients. Gut Liver. 2015;9(3):346–52.PubMedCrossRef Chang SS, Hu HY. Helicobacter pylori eradication within 120 days is associated with decreased complicated recurrent peptic ulcers in peptic ulcer bleeding patients. Gut Liver. 2015;9(3):346–52.PubMedCrossRef
31.
go back to reference Lin XH, Lin CC, Wang YJ, et al. Risk factors of the peptic ulcer bleeding in aging uremia patients under regular hemodialysis. J Chin Med Assoc. 2018;81(12):1027–32.PubMedCrossRef Lin XH, Lin CC, Wang YJ, et al. Risk factors of the peptic ulcer bleeding in aging uremia patients under regular hemodialysis. J Chin Med Assoc. 2018;81(12):1027–32.PubMedCrossRef
32.
go back to reference Romstad KK, Detlie TE, Søberg T, et al. Gastrointestinal bleeding due to peptic ulcers and erosions - a prospective observational study (BLUE study). Scand J Gastroenterol. 2020;55(10):1139–45.PubMedCrossRef Romstad KK, Detlie TE, Søberg T, et al. Gastrointestinal bleeding due to peptic ulcers and erosions - a prospective observational study (BLUE study). Scand J Gastroenterol. 2020;55(10):1139–45.PubMedCrossRef
33.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef
34.
go back to reference Bhattacharjee HK, Kaviyarasan MP, Singh KJ, et al. Age adjusted Charlson comorbidity index (a-CCI) as a tool to predict 30-day post-operative outcome in general surgery patients. ANZ J Surg. 2023;93(1–2):132–8.PubMedCrossRef Bhattacharjee HK, Kaviyarasan MP, Singh KJ, et al. Age adjusted Charlson comorbidity index (a-CCI) as a tool to predict 30-day post-operative outcome in general surgery patients. ANZ J Surg. 2023;93(1–2):132–8.PubMedCrossRef
35.
go back to reference Sim MMS, Shiferawe S, Wood JP. Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis. Front Cardiovasc Med. 2023;10:1272971.PubMedPubMedCentralCrossRef Sim MMS, Shiferawe S, Wood JP. Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis. Front Cardiovasc Med. 2023;10:1272971.PubMedPubMedCentralCrossRef
36.
go back to reference Tsoupras A, Gkika DA, Siadimas I, Christodoulopoulos I, Efthymiopoulos P, Kyzas GZ. The multifaceted effects of non-steroidal and non-opioid anti-inflammatory and analgesic drugs on platelets: current knowledge, limitations, and future perspectives. Pharmaceuticals (Basel). 2024;17(5):627.PubMedCrossRef Tsoupras A, Gkika DA, Siadimas I, Christodoulopoulos I, Efthymiopoulos P, Kyzas GZ. The multifaceted effects of non-steroidal and non-opioid anti-inflammatory and analgesic drugs on platelets: current knowledge, limitations, and future perspectives. Pharmaceuticals (Basel). 2024;17(5):627.PubMedCrossRef
37.
go back to reference Hágendorn R, Farkas N, Vincze Á, et al. Chronic kidney disease severely deteriorates the outcome of gastrointestinal bleeding: a meta-analysis. World J Gastroenterol. 2017;23(47):8415–25.PubMedPubMedCentralCrossRef Hágendorn R, Farkas N, Vincze Á, et al. Chronic kidney disease severely deteriorates the outcome of gastrointestinal bleeding: a meta-analysis. World J Gastroenterol. 2017;23(47):8415–25.PubMedPubMedCentralCrossRef
38.
go back to reference Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020;50(4):398–402.PubMedCrossRef Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020;50(4):398–402.PubMedCrossRef
39.
go back to reference Arai J, Kato J, Toda N, et al. Risk factors of poor prognosis and impairment of activities of daily living in patients with hemorrhagic gastroduodenal ulcers. BMC Gastroenterol. 2021;21(1):16.PubMedPubMedCentralCrossRef Arai J, Kato J, Toda N, et al. Risk factors of poor prognosis and impairment of activities of daily living in patients with hemorrhagic gastroduodenal ulcers. BMC Gastroenterol. 2021;21(1):16.PubMedPubMedCentralCrossRef
40.
go back to reference Xu Y, Siegal DM. Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants. J Thromb Haemost. 2021;19(10):2383–93.PubMedCrossRef Xu Y, Siegal DM. Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants. J Thromb Haemost. 2021;19(10):2383–93.PubMedCrossRef
41.
go back to reference Ayonrinde OT, Sanfilippo FM, Schultz C. Prescribing aspirin to older people - where is the line between cardiovascular benefit and upper gastrointestinal bleeding risk? Intern Med J. 2022;52(9):1468–70.PubMedCrossRef Ayonrinde OT, Sanfilippo FM, Schultz C. Prescribing aspirin to older people - where is the line between cardiovascular benefit and upper gastrointestinal bleeding risk? Intern Med J. 2022;52(9):1468–70.PubMedCrossRef
42.
go back to reference Kamal Ahmed F, Ahmed Mersal F. Abdel Kader mohamed W. Quality of life among elderly people with peptic ulcer at geriatric home. Egypt J Health Care. 2023;14(1):366–79.CrossRef Kamal Ahmed F, Ahmed Mersal F. Abdel Kader mohamed W. Quality of life among elderly people with peptic ulcer at geriatric home. Egypt J Health Care. 2023;14(1):366–79.CrossRef
43.
go back to reference Mard SA, Dehkohneh KA, Ahangarpour A. Decreased mRNA expression of cystathionine gamma lyase and H2S concentration in gastric mucosal tissue in diabetic rats. Braz Arch Biol Technol. 2018;61:e18160308.CrossRef Mard SA, Dehkohneh KA, Ahangarpour A. Decreased mRNA expression of cystathionine gamma lyase and H2S concentration in gastric mucosal tissue in diabetic rats. Braz Arch Biol Technol. 2018;61:e18160308.CrossRef
44.
go back to reference Liang CM, Hsu CN, Tai WC, et al. Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: a nationwide cohort study. Medicine. 2016;95(36):e4795.PubMedPubMedCentralCrossRef Liang CM, Hsu CN, Tai WC, et al. Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: a nationwide cohort study. Medicine. 2016;95(36):e4795.PubMedPubMedCentralCrossRef
45.
go back to reference Thanapirom K, Ridtitid W, Rerknimitr R, et al. Outcome of acute upper gastrointestinal bleeding in patients with coronary artery disease: a matched case-control study. Saudi J Gastroenterol. 2016;22(3):203–7.PubMedPubMedCentralCrossRef Thanapirom K, Ridtitid W, Rerknimitr R, et al. Outcome of acute upper gastrointestinal bleeding in patients with coronary artery disease: a matched case-control study. Saudi J Gastroenterol. 2016;22(3):203–7.PubMedPubMedCentralCrossRef
46.
47.
go back to reference Kalman RS, Pedrosa MC. Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient. Semin Dial. 2015;28(1):68–74.PubMedCrossRef Kalman RS, Pedrosa MC. Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient. Semin Dial. 2015;28(1):68–74.PubMedCrossRef
48.
go back to reference Islam R, Kundu S, Jha SB, et al. Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management. Cureus. 2022;14(4):e23785.PubMedPubMedCentral Islam R, Kundu S, Jha SB, et al. Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management. Cureus. 2022;14(4):e23785.PubMedPubMedCentral
49.
go back to reference Ardevol A, Ibañez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018;67(4):1458–71.PubMedCrossRef Ardevol A, Ibañez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018;67(4):1458–71.PubMedCrossRef
50.
go back to reference Infante VM, Román MY, Winograd LR, Ramos CJY, Rodríguez ÁD, Corujo AE. Influence of comorbidity on patients evolution with upper gastrointestinal bleeding from peptic ulcer. Rev Habanera De Cienc Medicas. 2016;15(4):551–62. Infante VM, Román MY, Winograd LR, Ramos CJY, Rodríguez ÁD, Corujo AE. Influence of comorbidity on patients evolution with upper gastrointestinal bleeding from peptic ulcer. Rev Habanera De Cienc Medicas. 2016;15(4):551–62.
51.
go back to reference Patel P, Nigam N, Sengupta N. Lower gastrointestinal bleeding in patients with coronary artery disease on antithrombotics and subsequent mortality risk. J Gastroenterol Hepatol. 2018;33(6):1185–91.PubMedCrossRef Patel P, Nigam N, Sengupta N. Lower gastrointestinal bleeding in patients with coronary artery disease on antithrombotics and subsequent mortality risk. J Gastroenterol Hepatol. 2018;33(6):1185–91.PubMedCrossRef
52.
go back to reference Sandek A, Swidsinski A, Schroedl W, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014;64(11):1092–102.PubMedCrossRef Sandek A, Swidsinski A, Schroedl W, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014;64(11):1092–102.PubMedCrossRef
54.
go back to reference Pourafkari L, Ghaffari S, Zamani N, et al. Upper gastrointestinal bleeding in the setting of excessive warfarin anticoagulation: risk factors, and clinical outcome. Cor et Vasa. 2017;59(2):e128–33.CrossRef Pourafkari L, Ghaffari S, Zamani N, et al. Upper gastrointestinal bleeding in the setting of excessive warfarin anticoagulation: risk factors, and clinical outcome. Cor et Vasa. 2017;59(2):e128–33.CrossRef
56.
go back to reference Mille M, Engelhardt T, Stier A. Bleeding duodenal ulcer: strategies in high-risk ulcers. Visc Med. 2021;37(1):52–62.PubMedCrossRef Mille M, Engelhardt T, Stier A. Bleeding duodenal ulcer: strategies in high-risk ulcers. Visc Med. 2021;37(1):52–62.PubMedCrossRef
57.
go back to reference Alsinnari YM, Alqarni MS, Attar M, et al. Risk factors for recurrence of peptic ulcer disease: a retrospective study in tertiary care referral center. Cureus. 2022;14:e22001.PubMedPubMedCentral Alsinnari YM, Alqarni MS, Attar M, et al. Risk factors for recurrence of peptic ulcer disease: a retrospective study in tertiary care referral center. Cureus. 2022;14:e22001.PubMedPubMedCentral
58.
go back to reference Solakoglu T, Koseoglu H, Atalay R, et al. Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding. Saudi J Gastroenterol. 2014;20(2):113–9.PubMedPubMedCentralCrossRef Solakoglu T, Koseoglu H, Atalay R, et al. Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding. Saudi J Gastroenterol. 2014;20(2):113–9.PubMedPubMedCentralCrossRef
Metadata
Title
Risk factors for peptic ulcer bleeding one year after the initial episode
Authors
Yu-Xuan Peng
Wen-Pei Chang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2024
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-024-00669-x

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more